Insulin resistance and vessel endothelial function - PubMed (original) (raw)
Review
. 2002;95 Suppl 42(Suppl 42):54-61.
Affiliations
- PMID: 12216328
- PMCID: PMC1308946
Review
Insulin resistance and vessel endothelial function
A J H H M van Oostrom et al. J R Soc Med. 2002.
Abstract
IRS is a complex disease consisting of a clustering of metabolic disorders, of which hyperglycaemia, hyper-insulinaemia and dyslipidaemia are the most important. Endothelial dysfunction plays an important role in the pathogenesis of atherosclerosis. The effects of hyperinsulinaemia seem to depend on lipidaemia and glycaemia. Hyperglycaemia and hyperlipidaemia have detrimental effects on endothelial function in the fasting as well as the postprandial states. In both situations, the generation of ROS and vasoactive molecules plays a major role in interfering with the atheroprotective endothelium-dependent NO system. Treatment of IRS in regard to endothelial function should be focused initially on lifestyle improvement, such as stopping smoking and eating a balanced diet containing antioxidant vitamins, folic-acid, L-arginine and long-chain omega-3 unsaturated FA. Strict glucose control has shown to improve endothelial function and decrease microvascular complications. However, macrovascular complications, in line with endothelial functional improvement, have so far been reduced only when treatment was focused on other characteristics of the IRS syndrome, in particular dyslipidaemia. Other relevant treatments include ACE inhibitors and thiazolidinediones, and probably tetrahydrobiopterin and folic acid supplementation. Future studies should address the effects of therapeutic neovascularization on endothelial dysfunction.
Similar articles
- The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome.
Rett K. Rett K. Diabetes Obes Metab. 1999 May;1 Suppl 1:S8-16. doi: 10.1046/j.1463-1326.1999.0010s1008.x. Diabetes Obes Metab. 1999. PMID: 11220289 Review. - The association between insulin resistance and endotheliopathy.
Tooke J. Tooke J. Diabetes Obes Metab. 1999 May;1 Suppl 1:S17-22. doi: 10.1046/j.1463-1326.1999.0010s1017.x. Diabetes Obes Metab. 1999. PMID: 11220284 Review. - Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.
Woodman RJ, Chew GT, Watts GF. Woodman RJ, et al. Drugs. 2005;65(1):31-74. doi: 10.2165/00003495-200565010-00003. Drugs. 2005. PMID: 15610050 Review. - [Clinical significance of blood glucose levels in the pathogenesis of (atherosclerotic) macroangiopathy].
Simon K. Simon K. Orv Hetil. 2004 Apr 18;145(16):861-6. Orv Hetil. 2004. PMID: 15156691 Review. Hungarian. - Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ, Ong MK, Lutterman JA, Smits P. Tack CJ, et al. Diabetologia. 1998 May;41(5):569-76. doi: 10.1007/s001250050948. Diabetologia. 1998. PMID: 9628275 Clinical Trial.
Cited by
- Angiotensin and insulin resistance: conspiracy theory.
Townsend RR. Townsend RR. Curr Hypertens Rep. 2003 Apr;5(2):110-6. doi: 10.1007/s11906-003-0066-1. Curr Hypertens Rep. 2003. PMID: 12642009 Review.
References
- Atherosclerosis. 2001 Feb 1;154(2):475-83 - PubMed
- Diabet Med. 1997 Aug;14 Suppl 3:S67-74 - PubMed
- Clin Sci (Lond). 1999 Aug;97(2):149-56 - PubMed
- Free Radic Biol Med. 1999 Oct;27(7-8):752-63 - PubMed
- J Clin Invest. 1997 Sep 1;100(5):1230-9 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous